My research focused on personalized therapy of nasopharyngeal carcinoma, and have publishedmany SCI papers as the first/co-first or corresponding/co- corresponding author, including in high-impact journals such as Nat Med, Cancer Cell, Sci Adv, Ann Oncol.

2021/08–2024/10 | Sun Yat-sen University Cancer Center, Department of Radiation Oncology, Postdoctoral Fellow

2018/09–2021/06 | PhD, Sun Yat-sen University, Oncology
2015/09–2018/06 | MSc,Sun Yat-sen University, Oncology

2010/09–2015/06 | Bachelor,Wuhan University, Clinical Medicine (5-year program)

1. Lv Jiawei ^(#), Wei Yuan ^(#), Yin Jian-Hua ^(#), Chen Yu-Pei ^(#), Zhou Guan-Qun ^(#), Wei Chen ^(#), Liang Xiao-Yu ^(#), Yuan Zhang^(#), Cui-Juan Zhang, Shi-Wei He, Qing-Mei He, Zhuo-Li Huang, Jia-Li Guan, Jia-Yi Shen, Xiao-Min Li, Jun-Yan Li, Wen-Fei Li, Ling-Long Tang, Yan-Ping Mao, Rui Guo, Rui Sun, Yu-Hui Zheng, Wen-Wen Zhou, Ke-Xu Xiong, Si-Qi Wang, Xin Jin, Na Liu^(*), Gui-Bo Li^(*), Dong-Ming Kuang^(*), Ying Sun^(*), Jun Ma^(*). The tumor immune microenvironment of nasopharyngeal carcinoma following gemcitabine plus cisplatin treatment. Nature Medicine. 2023 Jun;29(6):1424-1436. (IF 50, first author)

2. Lv Jiawei ^(#), Xu Ling-Xin^(#), Li Zhi-Xuan^(#), Lin Li^(#), Wu Chen-Fei^(#), Quan Ting-Qiu, Zhen Zi-Cheng, Li Wen-Fei, Tang Ling-Long, Mao Yan-Ping, Chen Lei, Guo Rui, Zhang Lu-Lu, Ai Xin-Lei, Wu Shi-Yue, Hao Meng-Yu, Wei Denghui, Li Ji-Bin, Ma Jun^(*), Chen Yu-Pei^(*), Zhou Guan-Qun^(*), Sun Ying^(*), Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON study, Cancer Cell, 2024, 42(8): 1401-1414. (IF 44.5, first author)

3. Wang Ya-Qin^(#), Wu Dong-Hong^(#), Wei Denghui^(#), Shen Jia-Yi^(#), Huang Zi-Wei^(#), Liang Xiao-Yu, William C S Cho, Ma Jun, Lv Jiawei^(*), Chen Yu-Pei^(*). TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma. Science Advance. 2023 Jan 6;9(1):eadd0960. (IF 12.5, co-corresponding author)

4. Lv Jiawei^(#), Chen Yu-Pei^(#), Zhou Guan-Qun^(#), Qi Zhen-Yu^(#), Tan Kuan-Rui, Lin  Li, Chen Fo-Ping, Zhang Lu-Lu, Huang Xiao-Dan, Liu Rui-Qi, Xu Si-Si, Chen Yue, Ma Jun, Chua Melvin^(*), Sun Ying^(*). Liquid biopsy tracking during sequential chemo-radiotherapy identifies distinct prognostic phenotypes in nasopharynx cancer. Nature Communications. 2019, 10(1): 3941. (IF 15.7, first author)

5. Wei Jiang^(#), Jia-Wei Lv^(#), Ling Long Tang^(#), Ying Sun, Yu Pei Chen^(*), Jun Ma^(*). Enhancing efficacy and reducing toxicity: Therapeutic optimization in locoregionally advanced nasopharyngeal carcinoma. Cell Report Medicine. 2024 Jun 18;5(6):101594. (IF 10.6, co-first author)

6. Lv Jiawei^(*)(#), Wu Chenfei^(#), Li Junyan^(#), Chen Foping^(#), He Shiwei^(#), Qingmei He, Zhou Guanqun, Ma Jun, Sun Ying^(*), Wei Denghui^(*), Lin Li^(*). Improving on‑treatment risk stratification of cancer patients with refined response classification and integration of circulating tumor DNA kinetics. BMC Medicine. 2022 Aug 23;20(1):268. (IF 8.3, first author)

7. Chen Yu-Pei^(#); Wang Ya-Qin^(#); Lv Jiawei ^(#); Li Ying-Qin^(#); Chua Melvin; Le Quynh-Thu; Lee, Nancy; Colevas A. Dimitrios; Seiwert Tanguy; Hayes D. Neil; Riaz Nadeem; Vermorken Jan B; O'Sullivan Brian; He Qing-Mei; Yang Xiao-Jing; Tang Ling-Long; Mao Yan-Ping; Sun Ying; Liu Na^(*); Ma Jun^(*). Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy. Annals of Oncology. 2019, 30(1): 68-75. (IF 65.4, co-first author, ESI Top 1% highly cited paper)

8. Chen Yu-Pei^(*)(#); Lv Jiawei ^(#); Mao Yan-Ping^(#); Li Xiao-Min^(#); Li Jun-Yan^(#); Wang Ya-Qin^(#); Xu Cheng; Li Ying-Qin; He Qing-Mei; Yang Xiao-Jing; Lei Yuan; Shen Jia-Yi; Tang Ling-Long; Chen Lei; Zhou Guan-Qun; Li Wen-Fei; Du Xiao-Jing; Guo Rui; Liu Xu; Zhang Yuan; Zeng Jing; Yun Jing-Ping; Sun Ying^(*); Liu Na^(*); Ma Jun^(*). Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses. Molecular Cancer. 2021, 20(1):14. (IF 33.9, co-first author)

9. Zhenyu Yang^(#), Yanfu Peng^(#), Yaqin Wang^(#), Panyang Yang, Zhuohui Huang, Tingqiu Quan, Xudong Xu, Peng Sun, Ying Sun, Jiawei Lv^(*), Denghui Wei^(*), Guan-Qun Zhou^(*) KLF5 regulates actin remodeling to enhance the metastasis of nasopharyngeal carcinoma. Oncogene. 2024 Apr 22. (IF 6.9, co-corresponding author)

10. Wu Chen-Fei^(#), Lv Jiawei ^(#), Lin Li^(#), Mao Yan-Ping^(#), Deng Bin^(#), Zheng Wei-Hong, Wen Dan-Wan, Chen Yue, Kou Jia, Chen Fo-Ping, Yang Xing-Li, Zheng Zi-Qi, Li Zhi-Xuan, Xu Si-Si, Ma Jun, Sun Ying^(*). Development and validation of a web-based calculator to predict individualized conditional risk of site-specific recurrence in nasopharyngeal carcinoma: Analysis of 10,058 endemic cases. Cancer Communications (Lond). 2021 Jan;41(1):37-50. (IF 24.9, co-first author)